An Investigation of the Anti-Parkinsonism Potential of Co-enzyme Q and Co-enzyme Q /Levodopa-carbidopa Combination in Mice.

Despite decades of research, neurodegenerative disorders like Parkinson's disease remain a leading cause of disability worldwide, due to the insufficient reduction of disease burden by available medications. Recently, the benefits of dietary supplements like co-enzyme Q in neurodegenerative diseases have been reported. ; Aim: The protective effects of supplemental co-enzyme Q (CQ) and possible additive benefits of CQ /Levodopa-Carbidopa (LD) in Chlorpromazine (CPZ)-induced Parkinsonism-like changes in mice were investigated.